FATE THERAPEUTICS INC (FATE) Total liabilities 2016–2025
FATE THERAPEUTICS INC (FATE) total liabilities at each fiscal year-end, per SEC filings.
$111.8MFY2025 · since FY2016: $21.9M → $111.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $111.8M | -8.4% |
| FY2024 | $122.0M | -11.5% |
| FY2023 | $137.8M | -37.8% |
| FY2022 | $221.6M | -8.7% |
| FY2021 | $242.6M | +1.9% |
| FY2020 | $238.0M | +313.8% |
| FY2019 | $57.5M | +9.4% |
| FY2018 | $52.6M | +87.0% |
| FY2017 | $28.1M | +28.4% |
| FY2016 | $21.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More FATE financial trends
FATE RevenueFATE Net incomeFATE Net marginFATE Gross profitFATE Gross marginFATE Operating incomeFATE Operating marginFATE Operating cash flowFATE Free cash flowFATE Capital expendituresFATE Return on equityFATE Stock buybacksFATE Dividends paidFATE Total assetsFATE Shareholders’ equityFATE overview →